Both in Biotechnology
Eikon Therapeutics vs Scribe Therapeutics
Over the past year EIKN returned −32.8% and SCTX returned −42.7%; their daily moves had a correlation of 0.21.
EIKN −32.8% SCTX −42.7%Growth of $1, one year, split-adjusted
| Metric | EIKN | SCTX |
|---|---|---|
| Price | $5.55 | $16.20 |
| Market cap | $300.6M | $306.7M |
| Today | −2.29% | +4.25% |
| 1 month | −26.4% | −0.1% |
| 6 months | −46.0% | — |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $531.2M | — |
| Dividend yield | — | — |
| Volatility (60d) | 99.9% | — |
| Short % of float | 20.4% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).